Revenue Growth: Burning Rock's revenue increased by 2.3% in the third quarter, primarily driven by a significant rise in R&D services, despite declines in its core cancer diagnostic products.
Stock Performance: The company's stock has tripled this year, with a notable 33% increase following its latest earnings report, reflecting investor optimism about its high gross margins and potential path to profitability.
Financial Challenges: Despite the revenue growth, Burning Rock continues to face high operating expenses, which accounted for 87% of its revenue, leading to a net loss that, while narrowed, still indicates ongoing financial struggles.
Market Position: The company has received approval for some products in Japan as companion diagnostics, but its global revenue remains weak, highlighting the uncertainty surrounding its growth prospects compared to other successful Chinese stocks.
Wall Street analysts forecast ZEPP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZEPP is 64.37 USD with a low forecast of 64.37 USD and a high forecast of 64.37 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast ZEPP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZEPP is 64.37 USD with a low forecast of 64.37 USD and a high forecast of 64.37 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 22.960
Low
64.37
Averages
64.37
High
64.37
Current: 22.960
Low
64.37
Averages
64.37
High
64.37
No data
About ZEPP
Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has two reportable segments the Xiaomi wearable products segment and Self-branded products and others segment.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
